Coronary Archives - iVascular

Email: info@ivascular.global | Tel: +34 936 724 711

About us
Therapeutic areas
- Coronary
- Peripheral
Clinical Trials
Healthcare Professionals
- PMS
- iVascular Grant
Careers
- Work with us
- Jobs board
News
Contact

Blog categories

All (18)
Clinical Trials (21)
Congresses (16)
Coronary (10)
Coronary and peripheral news (10)
Partnership (3)
Peripheral (21)

Comments

iVascular, Angiolite 6.00mm maximum overexpansion capacity.

January 13, 2021

iVascular, Angiolite 6.00mm maximum overexpansion capacity.

Clinical Trials

Angiolite is now reimbursed in Belgium.

September 3, 2020

Angiolite is now reimbursed in Belgium.

iVascular- MERLION Trial 6-month outcomes have been presented at VIVA 2020 Late breaking trial session.

June 26, 2020

iVascular- MERLION Trial 6-month outcomes have been presented at VIVA 2020 Late breaking trial session.

iVascular COVID 19 letter

June 15, 2020

iVascular COVID 19 letter

iVascular – essential pro, new coronary drug coated balloon

June 15, 2020

iVascular – essential pro, new coronary drug coated balloon

ANGIOLITE trial 2 years outcomes have been published at EuroIntervention

January 22, 2020

ANGIOLITE trial 2 years outcomes have been published at EuroIntervention

NAVITIAN

February 20, 2019

Navitian, iVascular´s new coronary microcatheter receives the CE mark approval

iVascular SLU received approval for selling its coronary and peripheral products in India

September 20, 2017

iVascular SLU received approval for selling its coronary and peripheral products in India

Capturer 7F has just received CE mark

March 20, 2017

Capturer 7F has just received CE mark

iVascular announces today that NC Xperience – non-compliant dilatation catheter – has received CE mark approval.

November 16, 2016

iVascular announces today that NC Xperience – non-compliant dilatation catheter – has received CE mark approval.

Search

Recent Posts

iVascular, Angiolite 6.00mm maximum overexpansion capacity. January 13, 2021
Angiolite is now reimbursed in Belgium. September 3, 2020
EffPac trial 2-year review on mortality confirms the safety of Luminor DCB September 3, 2020
iVascular is pleased to announce the launch of sergeant, a new peripheral support catheter July 10, 2020
iVascular- MERLION Trial 6-month outcomes have been presented at VIVA 2020 Late breaking trial session. June 26, 2020

Categories

All
Clinical Trials
Congresses
Coronary
Coronary and peripheral news
Partnership
Peripheral

iVascular S.L.U. | Camí de Can Ubach, 11 (Pol. Ind. Les Fallulles)
08620 Sant Vicenç dels Horts | Barcelona
Tel.: +34 936 724 711 | Fax: +34 936 724 657
Email: info@ivascular.global

Privacy Policy | Cookie Policy | Legal Disclaimer

#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}

Utilizamos cookies para garantizar la mejor experiencia en su navegación. Si continúa navegando considere aceptar el uso de cookies. Más información

Analytics

Privacy Preference Center

Política de Privacidad
Cookie Privacy

Consent Management

Política de Privacidad

Required

Introducción La presente Política de Privacidad ha sido desarrollada teniendo en cuenta lo dispuesto por la Ley Orgánica de Protección de Datos de carácter personal en vigor, así como por el Reglamento 2016/679 del Parlamento Europeo y del consejo del 27 de abril de 2016 relativo a la protección de las personas físicas en lo que respecta al tratamiento de datos personales y a la circulación de estos datos, en adelante el RGPD. Esta Política de Privacidad tiene por objeto poner en conocimiento de los titulares de los datos personales, respecto de los cuales se está recabando información, los aspectos específicos relativos al tratamiento sus datos, entre otras cosas, las finalidades de los tratamientos, los datos de contacto para ejercer los derechos que le asisten, los plazos de conservación de la información y las medidas de seguridad entre otras cosas.

Cookie Privacy

Required

Sus principales funciones son: Llevar el control de usuarios: cuando un usuario introduce su nombre de usuario y contraseña, se almacena una cookie para que no tenga que estar introduciéndolas para cada página del servidor. Sin embargo, una cookie no identifica solo a una persona, sino a una combinación de computador-navegador-usuario. Conseguir información sobre los hábitos de navegación del usuario, e intentos de spyware (programas espía), por parte de agencias de publicidad y otros. Esto puede causar problemas de privacidad y es una de las razones por la que las cookies tienen sus detractores.

Necessary

Analytics

Session-only

Cookies Used

ON OFF

Google Analytics

Other